Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Konstantin Tachkov

associate proffessor

medical university of sofia

Bulgaria

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (8)

Marlene Santos

Professor Coordenador

Instituto Politécnico de Leiria

PORTUGAL

View details

Denis Mulleman

Professor

Université de Tours

FRANCE

View details

Slaven Falamić

Assistant Professor

josip juraj strossmayer university of osijek

CROATIA

View details

Rumyana Simeonova

medical university of sofia

BULGARIA

View details

Antal Tamás Zemplenyi

associate professors

University of Pecs

HUNGARY

View details

Guenka Petrova

Professor

BULGARIA

View details

Zoltan Kalo

Professor of Health Economics

Semmelweis University

HUNGARY

View details

Tsanko Mondeshki

Assistant professor

medical university of sofia

BULGARIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Konstantin Tachkov

Research Interests

Make your next move.

Articles (20)

COVID‐19 Prophylactic Effect of Bromhexine Hydrochloride

Statement on education and scientific research in the field of therapeutic drug monitoring by the COST Action ENOTTA CA21147

Incorporating cost considerations into shared decision-making: A cross-country comparison among Hungary, France, and Bulgaria

Clinical outcomes in severe asthma patients switching biologic therapies: A real-world cohort analysis

Therapeutic drug monitoring education: The current state.

Real-life study of the cost-effectiveness of benralizumab vs previous care in Bulgaria

Incorporating cost considerations into shared decision-making: lessons from Bulgaria

High colchicine doses are more effective in COVID-19 outpatients than nirmatrelvir/ritonavir, remdesivir, and molnupiravir

Quality of life of patients with cardiomyopathy treated with sacubitril/valsartan vs. standard therapy during or after COVID-19 in Kazakhstan

Effect of increasing doses of colchicine on the treatment of 333 COVID‐19 inpatients

The role of insurance policies in the drug pricing landscape

Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making

Cost-effectiveness of therapeutic drug monitoring (TDM) of biologic treatment in rheumatic diseases: a narrative review

Study of Symptom Severity and Adherence to Therapy of Myelofibrosis Patients Treated with Ruxolitinib

Tackling reimbursement challenges to fair access to medicines – introduction to the topic

Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes

Analysis Of Patients' Opinion Of Prescribed Medicines: A Questionnaire - Based Pilot Study In Bulgaria

Evaluating potentially inappropriate medications in elderly patients in a pharmacy setting in Bulgaria: A pilot study utilizing the EU (7)-PIM List

Recommendations for patient involvement in health technology assessment in Central and Eastern European countries

Therapeutic Results and Survival of Patients with Myelofibrosis Treated with Ruxolitinib-A Real-Life Longitudinal Study

Collaborators (8)

Marlene Santos

Denis Mulleman

Slaven Falamić

Rumyana Simeonova

Antal Tamás Zemplenyi

Guenka Petrova

Zoltan Kalo

Tsanko Mondeshki

Make your next move.